Kevin M. Alexander - Publications

Susceptibility and screening approaches in systemic amyloidosis: expert perspectives from the International Society of Amyloidosis (ISA).

Journal: Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis

Published: September 04, 2026

Effect of acoramidis on risk of death and heart problem-related hospitalizations in people with transthyretin amyloid cardiomyopathy: a plain language summary.

Journal: Future cardiology

Published: August 05, 2026

Combination Therapy in ATTR Cardiomyopathy: Hypothesis-Generating, Not Yet Practice-Changing.

Journal: Journal of the American College of Cardiology

Published: August 05, 2026

Plain language summary of how acoramidis affects the total number of heart problems over time in people with ATTR-CM: findings from the ATTRibute-CM study.

Journal: Future cardiology

Published: August 03, 2026

Diagnosing Transthyretin Cardiac Amyloidosis in Japan: Lessons From J-COSSA on Access, Equity, and Earlier Detection.

Journal: JACC. Asia

Published: July 07, 2026

Temporal Trends in Incidence and Prevalence of Transthyretin Amyloid Cardiomyopathy in the United States.

Journal: Journal of the American Heart Association

Published: June 23, 2026

Delayed Diagnosis of Transthyretin Cardiac Amyloidosis Is Associated With Heart Failure Hospitalizations and Mortality.

Journal: JACC. Advances

Published: June 16, 2026

Long-term effects of acoramidis on mortality in variant transthyretin amyloid cardiomyopathy, including p.Val142Ile: findings from the open-label extension of ATTRibute-CM.

Journal: European journal of heart failure

Published: June 15, 2026

Diagnostic Trends and Geographic Health Care Disparities Among Patients With Transthyretin Amyloid Cardiomyopathy.

Journal: Journal of the American Heart Association

Published: June 09, 2026

Transthyretin Amyloid Cardiomyopathy in Women: Epidemiology, Diagnostic Delay, and Clinical Implications.

Journal: Cardiology and therapy

Published: June 03, 2026

Association Between Predicting Risk of Cardiovascular Disease Events (PREVENT) Risk Scores and Subclinical Cardiovascular Disease: Insights From the Project Baseline Health Study.

Journal: Journal of the American Heart Association

Published: May 30, 2026

Efficacy of Acoramidis in Transthyretin Amyloid Cardiomyopathy With and Without Atrial Fibrillation: Results From ATTRibute-CM.

Journal: Journal of cardiac failure

Published: May 08, 2026